Clinical Trial Update: Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and efficacy of NRT6008 in patients with unresectable locally advanced pancreatic cancer, sponsored by Chengdu Ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NRT6008

Snippet

Sponsor: Chengdu New Radiomedicine Technology Co. LTD. | Conditions: Unresectable Pancreatic Cancer | Phase 1 | Status: RECRUITING